Loading... Please wait...

Vertex Pharmaceuticals Incorporated (VRTX) Analyst Forecast

Currency in USD Disclaimer
$472.39 $2.11 (0.45%)
$471.79
$476.05
$335.82
$486.43
  • Consensus Rating

    Buy

    Based on 27 Analyst Ratings

  • Consensus Price Target

    $342.90

    -27.41% Downside

Recent Analyst Forecasts and Stock Ratings


Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside on Report Date Details
06/17/2024 Argus Research Jasper Hellweg $550.00 $474.61   15.88%
06/11/2024 RBC Capital Brian Abrahams $421.00 $483.28   -12.89%
05/31/2024 BMO Capital Evan David Seigerman $500.00 $443.05   12.85%
05/07/2024 Raymond James Christopher Raymond $456.00 $413.42   10.3%
05/07/2024 RBC Capital Brian Abrahams $424.00 $402.50   5.34%
04/11/2024 H.C. Wainwright Andrew Fein $462.00 $397.58   16.2%
04/11/2024 Evercore ISI Liisa Bayko $438.00 $397.58   10.17%
07/12/2022 Cantor Fitzgerald Olivia Brayer $365.00 $290.01   25.86%
07/11/2022 Stifel Nicolaus Paul Matteis $240.00 $295.46   -18.77%
07/01/2022 Argus Research Jasper Hellweg $280.00 $287.32   -2.55%
05/03/2022 Morgan Stanley Matthew Harrison $250.00 $261.96   -4.57%
04/05/2022 Oppenheimer Hartaj Singh $350.00 $272.39   28.49%
03/21/2022 BMO Capital Evan Seigerman $274.00 $251.88   8.78%
03/21/2022 Robert W. Baird Brian Skorney $240.00 $251.88   -4.72%
01/26/2022 J.P. Morgan Cory Kasimov $288.00 $228.22   26.19%
01/26/2022 Jefferies Michael Yee $275.00 $228.22   20.5%
01/26/2022 Wolfe Research Andrew Galler $282.00 $228.22   23.56%
01/26/2022 Morgan Stanley Matthew Harrison $208.00 $228.22   -8.86%
01/23/2022 Cowen & Co. Phil Nadeau $300.00 $229.68   30.62%
12/01/2021 Leerink Partners Geoff Porges $175.00 $204.45   -14.4%
11/30/2021 Guggenheim Debjit Chattopadhyay $286.00 $205.00   39.51%
11/01/2021 Bank of America Securities Geoff Meacham $275.00 $181.40   51.6%
06/10/2021 Cantor Fitzgerald Alethia Young $281.00 $193.02   45.58%
06/10/2021 Barclays Gena Wang $285.00 $193.02   47.65%
05/11/2021 UBS Colin Bristow $279.00 $212.68   31.18%

Vertex Pharmaceuticals Incorporated Frequently Asked Questions

  • Q. What analysts cover Vertex Pharmaceuticals Incorporated?

    A. Vertex Pharmaceuticals Incorporated has been rated by research analysts at Argus Research, RBC Capital, BMO Capital, Raymond James, H.C. Wainwright, Evercore ISI in the past 90 days.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.